未登录 分享 收藏
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer 简明语言总结: 劳拉替尼与克唑替尼在非小细胞肺癌中的CROWN研究的5年结果 Solomon, Benjamin J.; Liu, Geoffrey; Felip, Enriqueta; Mok, Tony S. K.; Soo, Ross A.; Mazieres, Julien; Shaw, Alice T.; de Marinis, Filippo; Goto, Yasushi; Wu, Yi-Long; Kim, Dong-Wan; Martini, Jean-Francois; Messina, Rossella; Paolini, Jolanda; Polli, Anna; Thomaidou, Despina; Toffalorio, Francesca; Bauer, Todd M. 分享 收藏
分享 收藏
Plain language summary of the updated results from the CROWN study comparing lorlatinib with crizotinib in people with advanced non-small-cell lung cancer CROWN研究更新结果的通俗解读：在晚期非小细胞肺癌患者中，洛拉替尼与克唑替尼的对比 Solomon, Benjamin J.; Bauer, Todd M.; Mok, Tony S. K.; Liu, Geoffrey; Mazieres, Julien; de Marinis, Filippo; Goto, Yasushi; Kim, Dong-Wan; Wu, Yi-Long; Jassem, Jacek; Lopez, Froylan Lopez; Soo, Ross A.; Shaw, Alice T.; Polli, Anna; Messina, Rossella; Iadeluca, Laura; Toffalorio, Francesca; Felip, Enriqueta 分享 收藏
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer Ravi, Arvind; Hellmann, Matthew D.; Arniella, Monica B.; Holton, Mark; Freeman, Samuel S.; Naranbhai, Vivek; Stewart, Chip; Leshchiner, Ignaty; Kim, Jaegil; Akiyama, Yo; Griffin, Aaron T.; Vokes, Natalie I.; Sakhi, Mustafa; Kamesan, Vashine; Rizvi, Hira; Ricciuti, Biagio; Forde, Patrick M.; Anagnostou, Valsamo; Riess, Jonathan W.; Gibbons, Don L.; Pennell, Nathan A.; Velcheti, Vamsidhar; Digumarthy, Subba R.; Mino-Kenudson, Mari; Califano, Andrea; Heymach, John V.; Herbst, Roy S.; Brahmer, Julie R.; Schalper, Kurt A.; Velculescu, Victor E.; Henick, Brian S.; Rizvi, Naiyer; Jaenne, Pasi A.; Awad, Mark M.; Chow, Andrew; Greenbaum, Benjamin D.; Luksza, Marta; Shaw, Alice T.; Wolchok, Jedd; Hacohen, Nir; Getz, Gad; Gainor, Justin F. 分享 收藏
Immunoproteasome expression and checkpoint blockade response in advanced non-small cell lung cancer Naranbhai, Vivek; Ravi, Arvind; Hellmann, Matthew; Arniella, Monica; Holton, Mark; Freeman, Samuel; Stewart, Chip; Leshchiner, Ignaty; Kim, Jaegil; Akiyama, Yo; Griffin, Aaron; Vokes, Natalie; Sakhi, Mustafa; Kamesan, Vashine; Rizvi, Hira; Ricciuti, Biagio; Forde, Patrick; Anagnostou, Valsamo; Riess, Jonathan; Gibbons, Don; Pennell, Nathan; Velcheti, Vamsidhar; Digumarthy, Subba; Mino-Kenudson, Mari; Califano, Andrea; Heymach, John; Herbst, Roy; Brahmer, Julie; Schalper, Kurt; Velculescu, Victor; Henick, Brian; Rizvi, Naiyer; Janne, Pasi; Awad, Mark; Chow, Andrew; Greenbaum, Benjamin; Luksza, Marta; Shaw, Alice; Wolchok, Jedd; Hacohen, Nir; Getz, Gad; Gainor, Justin 分享 收藏
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study 晚期ALK阳性非小细胞肺癌患者中，一线劳拉替尼对比克唑替尼的疗效与安全性：3期随机、开放标签CROWN研究数据的更新分析 Solomon, Benjamin J.; Bauer, Todd M.; Mok, Tony S. K.; Liu, Geoffrey; Mazieres, Julien; de Marinis, Filippo; Goto, Yasushi; Kim, Dong-Wan; Wu, Yi-Long; Jassem, Jacek; Lopez, Froylan Lopez; Soo, Ross A.; Shaw, Alice T.; Polli, Anna; Messina, Rossella; Iadeluca, Laura; Toffalorio, Francesca; Felip, Enriqueta 分享 收藏
分享 收藏
分享 收藏
A Phase 2 Study of Lorlatinib in Patients With ROS1-Rearranged Lung Cancer With Brain-Only Progression on Crizotinib Schneider, Jaime L.; Muzikansky, Alona; Lin, Jessica J.; Krueger, Elizabeth A.; Lennes, Inga T.; Jacobson, Joseph O.; Cheng, Michael; Heist, Rebecca S.; Piotrowska, Zofia; Gainor, Justin F.; Shaw, Alice T.; Dagogo-Jack, Ibiayi 分享 收藏
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial Mansfield, A. S.; Wei, Z.; Mehra, R.; Shaw, A. T.; Lieu, C. H.; Forde, P. M.; Drilon, A. E.; Mitchell, E. P.; Wright, J. J.; Takebe, N.; Sharon, E.; Hovelson, D.; Tomlins, S.; Zeng, J.; Poorman, K.; Malik, N.; Gray, R. J.; Li, S.; McShane, L. M.; Rubinstein, L., V; Patton, D.; Williams, P. M.; Hamilton, S. R.; Conley, B. A.; Arteaga, C. L.; Harris, L. N.; O'Dwyer, P. J.; Chen, A. P.; Flaherty, K. T. 分享 收藏
Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I/II study Lin, J. J.; Muzikansky, A.; Kennedy, E.; Kuberski, H.; Stober, L. L.; Wanat, A. C.; Azzoli, C. G.; Lennes, I; Sequist, L., V; Dagogo-Jack, I; Shaw, A. T.; Gainor, J. F. 分享 收藏
AN UPDATE ON THE STRATIFY (STAGING BY THORACOSCOPY IN POTENTIALLY RADICALLY TREATABLE NON-SMALL CELL LUNG CANCER ASSOCIATED WITH MINIMAL PLEURAL EFFUSION) STUDY Ferguson, J.; Rahman, N.; Maskell, N.; Lyons, J.; Grundy, S.; Sivakumar, D.; Corcoran, J.; Menzies, D.; Chalmers, A.; Alexander, L.; Kelly, C.; Shaw, A.; Dick, C.; Tsim, S.; Cowell, G.; Hopkins, T.; Woodward, R.; Blyth, K. G. 分享 收藏
Plain language summary of the CROWN study comparing lorlatinib with crizotinib for people with untreated non-small cell lung cancer Solomon, Benjamin J.; Bauer, Todd M.; de Marinis, Filippo; Felip, Enriqueta; Goto, Yasushi; Liu, Geoffrey; Mazieres, Julien; Kim, Dong-Wan; Mok, Tony; Polli, Anna; Thurm, Holger; Calella, Anna Maria; Peltz, Gerson; Shaw, Alice T. 分享 收藏
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs 洛拉替尼对先前接受第二代ALK TKIs治疗的ALK阳性非小细胞肺癌患者的颅内和颅外疗效 Felip, E.; Shaw, A. T.; Bearz, A.; Camidge, D. R.; Solomon, B. J.; Bauman, J. R.; Bauer, T. M.; Peters, S.; Toffalorio, F.; Abbattista, A.; Thurm, H.; Peltz, G.; Wiltshire, R.; Besse, B. 分享 收藏
Efficacy of Taletrectinib (AB-106/DS-6051b) in ROS1þ NSCLC: An Updated Pooled Analysis of U.S. and Japan Phase 1 Studies Ou, Sai-Hong Ignatius; Fujiwara, Yutaka; Shaw, Alice T.; Yamamoto, Noboru; Nakagawa, Kazuhiko; Fan, Frank; Hao, Yuki; Gao, Yanfei; Janne, Pasi A.; Seto, Takashi 分享 收藏
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer 一线氯拉替尼或克唑替尼治疗晚期ALK阳性肺癌 Shaw, Alice T.; Bauer, Todd M.; de Marinis, Filippo; Felip, Enriqueta; Goto, Yasushi; Liu, Geoffrey; Mazieres, Julien; Kim, Dong-Wan; Mok, Tony; Polli, Anna; Thurm, Holger; Calella, Anna M.; Peltz, Gerson; Solomon, Benjamin J. 分享 收藏
BRG1 Loss Predisposes Lung Cancers to Replicative Stress and ATR Dependency Gupta, Manav; Concepcion, Carla P.; Fahey, Caroline G.; Keshishian, Hasmik; Bhutkar, Arjun; Brainson, Christine F.; Sanchez-Rivera, Francisco J.; Pessina, Patrizia; Kim, Jonathan Y.; Simoneau, Antoine; Paschini, Margherita; Beytagh, Mary C.; Stanclift, Caroline R.; Schenone, Monica; Mani, D. R.; Li, Chendi; Oh, Audris; Li, Fei; Hu, Hai; Karatza, Angeliki; Bronson, Roderick T.; Shaw, Alice T.; Hata, Aaron N.; Wong, Kwok-Kin; Zou, Lee; Carr, Steven A.; Jacks, Tyler; Kim, Carla F. 分享 收藏
分享 收藏
Lorlatinib in patients with ALK plus NSCLC treated beyond initial disease progression Ou, S. I.; Solomon, B.; Shaw, A.; Gadgeel, S. M.; Besse, B.; Soo, R. A.; Abbattista, A.; Thurm, H.; Toffalorio, F.; Wiltshire, R. J.; Bearz, A. 分享 收藏
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
